Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209532PMID 16619043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.

  2005cited by this paper
• Chk1-Dependent S-M Checkpoint Delay in Vertebrate Cells Is Linked to Maintenance of Viable Replication Structures

  2005cited by this paper
• DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage*

  2005influential reference
• A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation

  2005cited by this paper
• Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

  2005cited by this paper
• Haemodynamic changes in heart failure induced by a new vasodilator tolesmoxide

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance.

  2004cited by this paper
• Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes

  2003cited by this paper
• Chk1‐deficient tumour cells are viable but exhibit multiple checkpoint and survival defects

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003influential reference
• Mechanisms of apoptosis induction by nucleoside analogs

  2003influential reference
• Chk1 and Chk2 kinases in checkpoint control and cancer.

  2003cited by this paper
• Toward maintaining the genome: DNA damage and replication checkpoints.

  2002cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• Activation of mammalian Chk1 during DNA replication arrest

  2001cited by this paper
• The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01*

  2000cited by this paper
• Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways.

  2000cited by this paper
• DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate.

  1986cited by this paper
• Fluorinated pyrimidines and their nucleosides.

  1983cited by this paper
• Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.

  1982cited by this paper
• Massive hepatobiliary ascariasis in childhood

  1981cited by this paper
• Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

  1974cited by this paper

• Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer

  2024cites this paper
• pH/H2 O2 Cascade-Responsive Nanoparticles of Lipid-Like Prodrugs through Dynamic-Covalent and Coordination Interactions for Chemotherapy.

  2024cites this paper
• ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

  2023cites this paper
• KRCC1, a modulator of the DNA damage response

  2022cites this paper
• Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer

  2018cites this paper
• The Future of 5-Fluorouracil Treatment of Colorectal Cancer: Translating a Better Understanding into Improved Patient Care

  2018cites this paper
• DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy.

  2017cites this paper
• AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11

  2017cites this paper
• University of Dundee AKT overactivation can suppress DNA repair via p 70 S 6 kinase-dependent downregulation of MRE 11

  2017cites this paper
• Pharmacokinetics, Tissue Distribution, Synergistic Activity, and Antitumor Activity of Two Isomeric Flavones

  2016cites this paper
• Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells

  2016cites this paper
• Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.

  2015cites this paper
• DNA damage-induced nuclear translocation of Apaf-1 is mediated by nucleoporin Nup107

  2015cites this paper
• The role of nucleotide excision repair factors and the Mre11 nuclease in nucleoside analogue sensitivity

  2015cites this paper
• Cancer therapy and replication stress: forks on the road to perdition.

  2015cites this paper
• Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil.

  2014cites this paper
• A Germline Polymorphism of Thymine DNA Glycosylase Induces Genomic Instability and Cellular Transformation

  2014cites this paper
• S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells.

  2013cites this paper
• SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.

  2013cites this paper
• The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.

  2013cites this paper
• The role of reactive oxygen species in cell death induced by thymidylate synthase inhibitors

  2013cites this paper
• Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines

  2012cites this paper
• Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics.

  2012cites this paper
• Proliferation rate but not mismatch repair affects the long-term response of colon carcinoma cells to 5FU treatment.

  2012cites this paper
• ATR-Chk1 signaling pathway and homologous recombinational repair protect cells from 5-fluorouracil cytotoxicity.

  2012cites this paper
• Avaliação dos mecanismos envolvidos na resposta aos danos no DNA induzidos pelo agente antitumoral 5-fluorouracil

  2012cites this paper
• The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.

  2012cites this paper
• Preclinical Development Preclinical Development of the Novel Chk 1 Inhibitor SCH 900776 in Combination with DNA-Damaging Agents and Antimetabolites

  2012cites this paper
• Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1

  2011cites this paper
• Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.

  2011cites this paper
• Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites

  2011cites this paper
• Therapeutics , Targets , and Chemical Biology Poly ( ADP-Ribose ) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells

  2011cites this paper
• Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil

  2011cites this paper
• DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.

  2011cites this paper
• Immuno-stabilizing effect of thymosin-alpha-1 on post- modified radical mastectomy (MRM) of breast cancer patients

  2011cites this paper
• Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2

  2010cites this paper
• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  2010cites this paper
• Targeting p21-Dependent Pathways for Cell Death in Cancer Therapy

  2010cites this paper
• ATR mediates cisplatin resistance in a p53 genotype-specific manner

  2010cites this paper
• Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival

  2009cites this paper
• Mirk Regulates the Exit of Colon Cancer Cells from Quiescence*

  2009cites this paper
• Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-Fluorouracil

  2009cites this paper
• Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway

  2009cites this paper
• Participation of DNA repair in the response to 5-fluorouracil

  2009cites this paper
• Running title : Rad 9 and ATR , but not Chk 1 , reduce cisplatin tumor killing

  2009cites this paper
• Nucleoside analogs: molecular mechanisms signaling cell death

  2008cites this paper
• Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.

  2008cites this paper
• Uracil in DNA: consequences for carcinogenesis and chemotherapy.

  2008cites this paper
• DNA damage and homologous recombination signaling induced by thymidylate deprivation.

  2008cites this paper
• Checkpoint Kinase 1 Down-Regulation by an Inducible Small Interfering RNA Expression System Sensitized In vivo Tumors to Treatment with 5-Fluorouracil

  2008cites this paper
• Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells

  2008cites this paper
• Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation

  2008cites this paper
• Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo

  2007cites this paper
• Checkpoint Kinase 1 Down-regulation by an Inducible Small Interfering Rna Expression System Sensitized in Vivo Tumors Totreatment with 5-fluorouracil Cancer Therapy: Preclinical Materials and Methods

  year unknowncites this paper